These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657 [TBL] [Abstract][Full Text] [Related]
6. Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine. Kobashigawa JA Transplant Proc; 1998 Jun; 30(4):1095-7. PubMed ID: 9636445 [No Abstract] [Full Text] [Related]
7. Experience with cyclosporine in endogenous uveitis posterior. Hesselink DA; Baarsma GS; Kuijpers RW; van Hagen PM Transplant Proc; 2004 Mar; 36(2 Suppl):372S-377S. PubMed ID: 15041371 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies. Nguyen QD; Merrill PT; Sepah YJ; Ibrahim MA; Banker A; Leonardi A; Chernock M; Mudumba S; Do DV Ophthalmology; 2018 Dec; 125(12):1984-1993. PubMed ID: 30060978 [TBL] [Abstract][Full Text] [Related]
9. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Kilmartin DJ; Forrester JV; Dick AD Ocul Immunol Inflamm; 1998 Jun; 6(2):101-9. PubMed ID: 9689640 [TBL] [Abstract][Full Text] [Related]
10. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporin or tacrolimus: which agent to choose? Danovitch GM Nephrol Dial Transplant; 1997 Aug; 12(8):1566-8. PubMed ID: 9269630 [No Abstract] [Full Text] [Related]
13. Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis. Imrie FR; Dick AD Curr Opin Ophthalmol; 2007 May; 18(3):212-9. PubMed ID: 17435428 [TBL] [Abstract][Full Text] [Related]
14. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. Arnold JC; Theilmann L Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559 [No Abstract] [Full Text] [Related]
16. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Lowder C; Belfort R; Lightman S; Foster CS; Robinson MR; Schiffman RM; Li XY; Cui H; Whitcup SM; Arch Ophthalmol; 2011 May; 129(5):545-53. PubMed ID: 21220619 [TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Dick AD; Azim M; Forrester JV Br J Ophthalmol; 1997 Dec; 81(12):1107-12. PubMed ID: 9497474 [No Abstract] [Full Text] [Related]
18. Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents. Walton RC; Nussenblatt RB; Whitcup SM Ophthalmology; 1998 Nov; 105(11):2028-34. PubMed ID: 9818601 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine and tacrolimus in dermatology. Cather JC; Abramovits W; Menter A Dermatol Clin; 2001 Jan; 19(1):119-37, ix. PubMed ID: 11155577 [TBL] [Abstract][Full Text] [Related]